Article Tools

Massive Losses for Intercell

Published: March 2, 2011; 00:00 · (Vindobona)

The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.

Massive Losses for Intercell / Picture: © Vindobona.org

Today Intercell AG (VSE: ICLL) announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company’s development programs.

In 2010, Intercell experienced a serious backdrop in its development. Due to a cancelled program for the development of vaccines, the company had to…

This article includes a total of 1210 words.

or Log In